Novartis drug helps prevent breast cancer recurrence
15th Dec 2005, 12:54 GMT
A trial has shown that women with early breast cancer who took the Novartis drug Femara experienced a significant benefit up to five years after the end of chemotherapy.
Novartis drug helps prevent breast cancer recurrence related news:
- More good news - Femara helps prevent the return of breast cancer — News-Medical News Feed
- Aromatase inhibitor shows promise for breast cancer patients — The Cancer Blog
- Taking Hormonal Therapy Right to Prevent Recurrence — Breast Cancer Chronicles
- Breast cancer drug may work in lung cancer — United Press International - Health Business
- San Antonio Breast Cancer Symposium Research Shows Hormone Replacement Therapy is No Help for Women Taking Tamoxifen — Mammography News from StratCenter.com
- SABCS: Shorter Chemotherapy Regimen Plus Taxol Reduces Breast Cancer Recurrence — MedPage Today Hematology/Oncology
- NHS under pressure to provide new breast cancer drugs — News-Medical News Feed
- Radiotherapy aids breast cancer survival — MSNBC.com: Health
- Genomic Health Announces Study Results Demonstrating Oncotype DX 's Ability to Quantify Risk for Local and Regional Breast Cancer Recurrence — Surgery News from StratCenter.com
- Radiotherapy aids breast cancer survival - study — KeralaNext: International
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol